Loading clinical trials...
Loading clinical trials...
Subjective cognitive decline (SCD) represents the initial clinical manifestation in the disease spectrum of Alzheimer's Disease (AD). It represents an essential stage for early prevention and treatmen...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Zheng Li
NCT07457138 · Subjective Cognitive Decline (SCD), Functional Cognitive Disorder, and more
NCT07286448 · Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)
NCT07212504 · Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)
NCT06403345 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT06632145 · Subjective Cognitive Decline (SCD)
School of Nursing, Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions